LINC02682
LINC02682 is highly expressed and correlates with worse risk stratification and poor treatment outcomes,and promotes cell proliferation while represses apoptosis in pediatric Acute myeloid leukemia.[1]
Contents
Annotated Information
Name
Approved symbol:LINC02682
HGNC ID:54177
Approved name:long intergenic non-protein coding RNA 2682
Alias symbol:TCONS_00019584|lnc-SOX6-1
RefSeq ID:XR_931078
Characteristics
location:11p15.2
Function
LINC02682 upregulation correlates with poor risk stratification and worse treatment outcomes, and promotes cell proliferation while inhibits apoptosis in pediatric acute myeloid leukemia[1]
Regulation
Please input information here.
Expression
LINC02682 expression was elevated in various AML cells compared to normal cells. [1]
Diseases
Acute myeloid leukemia (AML) [1]
Labs working on this lncRNA
- Department of Hematology and Oncology, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.[1]
- Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.[1]
- Chongqing Key Laboratory of Pediatrics, Chongqing, China.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Guan X, Wen X, Xiao J, An X, Yu J, Guo Y. Lnc-SOX6-1 upregulation correlates with poor risk stratification and worse treatment outcomes, and promotes cell proliferation while inhibits apoptosis in pediatric acute myeloid leukemia. Int J Lab Hematol. 2019 Apr;41(2):234-241. doi: 10.1111/ijlh.12952. Epub 2019 Jan 9. PMID: 30624855.
